147 related articles for article (PubMed ID: 32382939)
1. Choices, attitudes, and experiences of genetic screening in Latino/a and Ashkenazi Jewish individuals.
Reed-Weston AE; Espinal A; Hasar B; Chiuzan C; Lazarin G; Weng C; Appelbaum PS; Chung WK; Wynn J
J Community Genet; 2020 Oct; 11(4):391-403. PubMed ID: 32382939
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Effectiveness of a Telehealth Cancer Genetics Program: A BRCA Pilot Study.
Rose E; Hardy MW; Gates R; Stanislaw C; Meisel J; Grinzaid KA
Public Health Genomics; 2022 Aug; ():1-14. PubMed ID: 35944511
[TBL] [Abstract][Full Text] [Related]
3. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.
Lewis MJ; Peterson SK
Community Genet; 2007; 10(2):72-81. PubMed ID: 17380056
[TBL] [Abstract][Full Text] [Related]
4. Experiences of Latino Participants Receiving Neutral Genomic Screening Results: A Qualitative Study.
Cheema AW; Sutton EJ; Beck AT; Cuellar I; Moreno Garzon GG; Hernandez V; Lindor NM; Shaibi GQ; Kullo IJ; Sharp RR
Public Health Genomics; 2021 Feb; 24(1-2):44-53. PubMed ID: 33592611
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease-causing variants.
Shi L; Webb BD; Birch AH; Elkhoury L; McCarthy J; Cai X; Oishi K; Mehta L; Diaz GA; Edelmann L; Kornreich R
Clin Genet; 2017 Apr; 91(4):599-604. PubMed ID: 27415407
[TBL] [Abstract][Full Text] [Related]
6. Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases.
Eng CM; Desnick RJ
Adv Genet; 2001; 44():275-96. PubMed ID: 11596990
[TBL] [Abstract][Full Text] [Related]
7. Clinicians' attitudes toward general screening of the Ashkenazi-Jewish population for prevalent founder BRCA1/2 and LRRK2 mutations.
Shkedi-Rafid S; Ofer-Bialer G; Meiner V; Calderon-Margalit R
Public Health Genomics; 2013; 16(4):174-83. PubMed ID: 23816973
[TBL] [Abstract][Full Text] [Related]
8. Online Module for Carrier Screening in Ashkenazi Jewish Individuals Compared with In-Person Genetics Education: A Randomized Controlled Trial.
Fan CW; Castonguay L; Rummell S; Lévesque S; Mitchell JJ; Sillon G
J Genet Couns; 2018 Apr; 27(2):426-438. PubMed ID: 28791521
[TBL] [Abstract][Full Text] [Related]
9. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
10. Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening.
Grinzaid KA; Page PZ; Denton JJ; Ginsberg J
J Genet Couns; 2015 Jun; 24(3):381-7. PubMed ID: 25502003
[TBL] [Abstract][Full Text] [Related]
11. Knowledge, attitudes, and barriers to carrier screening for the Ashkenazi Jewish panel: a Florida experience : Education and Barriers assessment for Jewish Genetic Diseases.
Warsch JR; Warsch S; Herman E; Zakarin L; Schneider A; Hoffman J; Wasserman D; Barbouth D
J Community Genet; 2014 Jul; 5(3):223-31. PubMed ID: 24415495
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
Frey MK; Kopparam RV; Ni Zhou Z; Fields JC; Buskwofie A; Carlson AD; Caputo T; Holcomb K; Chapman-Davis E
Cancer; 2019 Mar; 125(5):690-697. PubMed ID: 30480775
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
Sinclair P; Kable A; Levett-Jones T
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
[TBL] [Abstract][Full Text] [Related]
14. Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.
Lew RM; Burnett L; Proos AL; Barlow-Stewart K; Delatycki MB; Bankier A; Aizenberg H; Field MJ; Berman Y; Fleischer R; Fietz M
J Paediatr Child Health; 2015 Mar; 51(3):271-9. PubMed ID: 24923490
[TBL] [Abstract][Full Text] [Related]
15. Community attitudes towards a Jewish community BRCA1/2 testing program.
Cousens N; Kaur R; Meiser B; Andrews L
Fam Cancer; 2017 Jan; 16(1):17-28. PubMed ID: 27480161
[TBL] [Abstract][Full Text] [Related]
16. Personal genomic screening: How best to facilitate preparedness of future clients.
Fleming J; Terrill B; Dziadek M; Kirk EP; Roscioli T; Barlow-Stewart K
Eur J Med Genet; 2019 May; 62(5):397-404. PubMed ID: 31085343
[TBL] [Abstract][Full Text] [Related]
17. Prenatal genetic carrier testing using triple disease screening.
Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing uptake of genetic testing for colorectal cancer risk in an Australian Jewish population.
Warner BJ; Curnow LJ; Polglase AL; Debinski HS
J Genet Couns; 2005 Oct; 14(5):387-94. PubMed ID: 16195945
[TBL] [Abstract][Full Text] [Related]
19. Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes.
Frey MK; Sandler G; Sobolev R; Kim SH; Chambers R; Bassett RY; Martineau J; Sapra KJ; Boyd L; Curtin JP; Pothuri B; Blank SV
Gynecol Oncol; 2017 Jul; 146(1):123-128. PubMed ID: 28495237
[TBL] [Abstract][Full Text] [Related]
20. Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes.
Manchanda R; Burnell M; Gaba F; Desai R; Wardle J; Gessler S; Side L; Sanderson S; Loggenberg K; Brady AF; Dorkins H; Wallis Y; Chapman C; Jacobs C; Legood R; Beller U; Tomlinson I; Menon U; Jacobs I
BJOG; 2020 Feb; 127(3):364-375. PubMed ID: 31507061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
